
    
      Approximately, 80% of breast cancer survivors undergoing will suffer from a permanent reduced
      reduction in nipple sensitivity and associated lowerdecrease in sexual quality of life.
      Currently, there are no treatments for restoring nipple sensitivity and the associatedto
      improve lower sexual quality of life this condition. It would thus be of great clinical
      benefit to post breast surgery patients if a provide a new safe and , effective , topical ,
      on-demand, treatment for this condition can be developed.
    
  